title: Pirfenidone for idiopathic pulmonary fibrosis, thrombocytosis in chronic obstructive pulmonary disease exacerbations, and a longitudinal study on e-cigarettes.
authors.affiliation: Pulmonary and Critical Care Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
authors.forename: Sugeet
authors.initials: S
authors.lastname: Jagpal
authors.forename: Oleksandr
authors.initials: O
authors.lastname: Pistun
authors.forename: John
authors.initials: J
authors.lastname: Mikhail
mesh_terms: D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000706:statistics & numerical data*; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D008297:Male; D009538:Nicotine / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000401:mortality*; D011728:Pyridones / Q000627:therapeutic use*; D012907:Smoking; D016540:Smoking Cessation / Q000379:methods*; D013922:Thrombocytosis / Q000188:drug therapy* / Q000401:mortality*; D013988:Ticlopidine / Q000031:analogs & derivatives*; D061485:Tobacco Use Cessation Devices / Q000706:statistics & numerical data*
chemical_list: D000933:Antifibrinolytic Agents; D004791:Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors; D011728:Pyridones; D009538:Nicotine; D013988:Ticlopidine; D001241:Aspirin